2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015-2030.
Daniel F Battafarano, Marcia Ditmyer, Marcy B Bolster...
https://pubmed.ncbi.nlm.nih.gov/29400009/Actively Recruiting
Led by St. Lawrence Health System · Updated on 2025-06-24
100
Participants Needed
1
Research Sites
N/A
Total Duration
Rheumatoid arthritis RA is a chronic autoimmune disease where the immune system attacks joint tissue, causing pain, swelling, and stiffness. This condition affects about 1.5 million people in the US and can lead to serious joint damage if untreated. Access to specialized rheumatology care is limited, especially in rural areas like northern New York, making it difficult for many patients to receive proper treatment. This trial evaluates whether trained primary care providers PCPs can manage stable RA patients as effectively as rheumatologists, potentially improving care access in underserved regions. In this randomized controlled trial, patients with stable RA will be assigned to either continue care with their usual rheumatologist or receive care from a PCP who has completed a structured RA training program. Nine PCPs underwent training including lectures, case studies, and exams, with ongoing monthly case reviews with rheumatology specialists. The study will enroll up to 100 participants and follow them for one year, comparing the two care models. The intervention group receives RA management from trained PCPs, while the control group continues usual care in a rheumatology clinic. Participants will attend visits at screeningbaseline, 6 weeks, 12 weeks, 26 weeks, 40 weeks, and 52 weeks. Assessments include standard RA activity measures like MDHAQ, joint counts, disease activity scores DAS28, CDAI, SDAI, glucocorticoid exposure, patient-reported outcomes, and medical records review. The main outcome is change in DAS-28 at 6 and 12 months. This study will monitor patient status and safety throughout the year to evaluate if PCP-led care can maintain disease control and improve access for rural RA patients.
CONDITIONS
Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial
M
McKailey Lyndaker
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
St. Lawrence Health System
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | PCP with structured RA training and monthly rheumatology consultation | Specialist rheumatologist manages RA care |
|---|---|---|
| What is it? | Patients are managed for their rheumatoid arthritis by their primary care provider, who has completed a specialized RA training course and participates in monthly case review sessions with rheumatologists. | Patients receive their rheumatoid arthritis care directly from a specialist rheumatologist according to established clinical practice. |
| Role in the trial | This arm tests whether trained PCPs, with monthly specialist support, can provide effective RA management similar to specialist care. | This arm represents usual specialist rheumatologist care and serves as the standard comparator for evaluating PCP-led management. |
| Primary use in clinical care | Primary care management after specialist training could expand access for patients in areas with limited rheumatology workforce, particularly when ongoing case review is available. | Specialist rheumatologist-led care remains the established clinical standard for RA management, and is recommended for diagnosis and complex care. |
| How is it given or performed? | PCPs manage RA care following completion of a structured training course and participate in monthly case reviews with rheumatology specialists to support ongoing decisions. | Rheumatologists provide direct patient care using specialist clinical protocols, diagnostic expertise, and medication management for RA. |
| Evidence status | Outcome evidence is not yet posted for PCP-led RA management with structured training. The trial is ongoing and results will inform whether this approach achieves disease control comparable to specialist-led care. | Rheumatologist-led care is supported as established clinical practice for RA, per workforce and guideline evidence. RA outcomes rely on specialist assessment and disease-modifying therapy management. |
| Important limitations | Effectiveness of PCP-led management depends on quality and completeness of specialist training, ongoing access to rheumatology consultation, and stable disease status. Complex cases and rare manifestations may require specialist referral. | Specialist care may be less accessible in rural areas due to rheumatology workforce shortages, leading to delays or barriers for patients needing RA management. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 52 weeks
Participants receive rheumatoid arthritis care either from their trained primary care provider or from a rheumatology clinic. Care includes monthly case review sessions with the rheumatology team and ad hoc consultations as needed.
Visits at baseline, 6 weeks, 12 weeks, 26 weeks, 40 weeks, and 52 weeks
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Daniel F Battafarano, Marcia Ditmyer, Marcy B Bolster...
https://pubmed.ncbi.nlm.nih.gov/29400009/St. Lawrence Health System
Lead Sponsor